ABL-class Genomic Breakpoint Q-PCR: A Patient-specific Approach for MRD Monitoring in Acute Lymphoblastic Leukemia

Bibliographic Details
Main Authors: Inge van Outersterp, Vincent H.J. van der Velden, Patricia G. Hoogeveen, Goda E. Vaitkevičienė, Edwin Sonneveld, Gijs van Haaften, Roland P. Kuiper, Udo zur Stadt, Gabriele Escherich, Judith M. Boer, Monique L. den Boer
Format: Article
Language:English
Published: Wiley 2023-10-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/HS9.0000000000000967
_version_ 1797226057488662528
author Inge van Outersterp
Vincent H.J. van der Velden
Patricia G. Hoogeveen
Goda E. Vaitkevičienė
Edwin Sonneveld
Gijs van Haaften
Roland P. Kuiper
Udo zur Stadt
Gabriele Escherich
Judith M. Boer
Monique L. den Boer
author_facet Inge van Outersterp
Vincent H.J. van der Velden
Patricia G. Hoogeveen
Goda E. Vaitkevičienė
Edwin Sonneveld
Gijs van Haaften
Roland P. Kuiper
Udo zur Stadt
Gabriele Escherich
Judith M. Boer
Monique L. den Boer
author_sort Inge van Outersterp
collection DOAJ
first_indexed 2024-03-11T15:07:21Z
format Article
id doaj.art-ef1fe8fac5a545b3a961b76a6c0583e7
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-04-24T14:18:51Z
publishDate 2023-10-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-ef1fe8fac5a545b3a961b76a6c0583e72024-04-03T08:04:47ZengWileyHemaSphere2572-92412023-10-01710e96710.1097/HS9.0000000000000967202310000-00005ABL-class Genomic Breakpoint Q-PCR: A Patient-specific Approach for MRD Monitoring in Acute Lymphoblastic LeukemiaInge van Outersterp0Vincent H.J. van der Velden1Patricia G. Hoogeveen2Goda E. Vaitkevičienė3Edwin Sonneveld4Gijs van Haaften5Roland P. Kuiper6Udo zur Stadt7Gabriele Escherich8Judith M. Boer9Monique L. den Boer101 Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands2 Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center Rotterdam, The Netherlands2 Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center Rotterdam, The Netherlands3 Faculty of Medicine, Vilnius University, Lithuania1 Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands6 Department of Genetics, University Medical Center Utrecht, The Netherlands1 Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands7 Department of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Germany7 Department of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Germany1 Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands1 Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlandshttp://journals.lww.com/10.1097/HS9.0000000000000967
spellingShingle Inge van Outersterp
Vincent H.J. van der Velden
Patricia G. Hoogeveen
Goda E. Vaitkevičienė
Edwin Sonneveld
Gijs van Haaften
Roland P. Kuiper
Udo zur Stadt
Gabriele Escherich
Judith M. Boer
Monique L. den Boer
ABL-class Genomic Breakpoint Q-PCR: A Patient-specific Approach for MRD Monitoring in Acute Lymphoblastic Leukemia
HemaSphere
title ABL-class Genomic Breakpoint Q-PCR: A Patient-specific Approach for MRD Monitoring in Acute Lymphoblastic Leukemia
title_full ABL-class Genomic Breakpoint Q-PCR: A Patient-specific Approach for MRD Monitoring in Acute Lymphoblastic Leukemia
title_fullStr ABL-class Genomic Breakpoint Q-PCR: A Patient-specific Approach for MRD Monitoring in Acute Lymphoblastic Leukemia
title_full_unstemmed ABL-class Genomic Breakpoint Q-PCR: A Patient-specific Approach for MRD Monitoring in Acute Lymphoblastic Leukemia
title_short ABL-class Genomic Breakpoint Q-PCR: A Patient-specific Approach for MRD Monitoring in Acute Lymphoblastic Leukemia
title_sort abl class genomic breakpoint q pcr a patient specific approach for mrd monitoring in acute lymphoblastic leukemia
url http://journals.lww.com/10.1097/HS9.0000000000000967
work_keys_str_mv AT ingevanoutersterp ablclassgenomicbreakpointqpcrapatientspecificapproachformrdmonitoringinacutelymphoblasticleukemia
AT vincenthjvandervelden ablclassgenomicbreakpointqpcrapatientspecificapproachformrdmonitoringinacutelymphoblasticleukemia
AT patriciaghoogeveen ablclassgenomicbreakpointqpcrapatientspecificapproachformrdmonitoringinacutelymphoblasticleukemia
AT godaevaitkeviciene ablclassgenomicbreakpointqpcrapatientspecificapproachformrdmonitoringinacutelymphoblasticleukemia
AT edwinsonneveld ablclassgenomicbreakpointqpcrapatientspecificapproachformrdmonitoringinacutelymphoblasticleukemia
AT gijsvanhaaften ablclassgenomicbreakpointqpcrapatientspecificapproachformrdmonitoringinacutelymphoblasticleukemia
AT rolandpkuiper ablclassgenomicbreakpointqpcrapatientspecificapproachformrdmonitoringinacutelymphoblasticleukemia
AT udozurstadt ablclassgenomicbreakpointqpcrapatientspecificapproachformrdmonitoringinacutelymphoblasticleukemia
AT gabrieleescherich ablclassgenomicbreakpointqpcrapatientspecificapproachformrdmonitoringinacutelymphoblasticleukemia
AT judithmboer ablclassgenomicbreakpointqpcrapatientspecificapproachformrdmonitoringinacutelymphoblasticleukemia
AT moniqueldenboer ablclassgenomicbreakpointqpcrapatientspecificapproachformrdmonitoringinacutelymphoblasticleukemia